Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Boris E. Reisberg is active.

Publication


Featured researches published by Boris E. Reisberg.


Progress in Cardiovascular Diseases | 1979

Infective endocarditis in the narcotic addict

Boris E. Reisberg

As long as the illicit use of heroin and other drugs continues in our society, infective endocarditis will remain a significant medical problem in the drug-using population. The majority of infections are produced by S. aureus, and the tricuspid valve is most commonly involved. Addicts, unlike the general population, may also develop endocarditis with a variety of gram-negative bacilli and have a higher incidence of fungal infection. The outcome of each individual infection is dependent on the prompt recognition of the underlying valvular infection and the institution of antimicrobial therapy. Infection of the tricuspid valve has a much more favorable prognosis than does infection of the aortic or mitral valves. Fungal endocarditis, and frequently gram-negative bacillary endocarditis, require valvular surgery to effect a cure.


International Journal of Antimicrobial Agents | 1998

Management of fluoroquinolone resistance in Pseudomonas aeruginosa--outcome of monitored use in a referral hospital.

Lance R. Peterson; Michael Postelnick; T.L Pozdol; Boris E. Reisberg; Gary A. Noskin

We evaluated a strategy designed to improve useful activity of ciprofloxacin against Pseudomonas aeruginosa. Following changes in antimicrobial agent use made by the institutional Pharmacy and Therapeutic Drug Committee, monthly drug usage and microbial susceptibility records from June 1992 through October 1995 were reviewed. From July 1992 through October 1992 (Period 1), ciprofloxacin and ofloxacin usage represented 95 and 5% of total quinolone doses; from December 1992 to March 1993 (Period 2), ciprofloxacin represented 19%; from July 1993 to October 1993 (Period 3), ciprofloxacin usage represented 85%; from July 1994 to October 1994 (Period 4), ciprofloxacin represented 95%; and from July 1995 to October 1995 (Period 5), ciprofloxacin and ofloxacin respectively represented 98 and 2% of total quinolone doses. Comparison of the anti-pseudomonal activity of the two fluoroquinolones to ofloxacin use, ciprofloxacin use and total quinolone use during the entire observational period showed the highest (negative) correlation with ofloxacin use versus ofloxacin activity (y = -15.04x + 1367.99, r2 = 0.06, w = 0.126). Increased use of quinolones plus a change to primarily ofloxacin usage appeared to adversely affect the activity of both ofloxacin and ciprofloxacin against P. aeruginosa.


Diagnostic Microbiology and Infectious Disease | 1996

Molecular typing for investigating an outbreak of Candida krusei

Gary A. Noskin; Jenny K. Lee; Donna M. Hacek; Michael Postelnick; Boris E. Reisberg; Valentina Stosor; Sigmund A. Weitzman; Lance R. Peterson

Invasive infections due to Candida krusei are often observed in immunocompromised patients who have received prior therapy with fluconazole, although infection has also occurred in patients in the absence of this antifungal agent. From August 25 through September 19, 1995, we identified four patients with C. krusei fungemia on our hematology/oncology unit. Molecular typing of all the isolates was performed by restriction endonuclease analysis of genomic DNA using HinfI. A total of 7 patients found to be colonized or infected with C. krusei were matched with 14 controls. There was no difference between the cases and controls with respect to underlying disease, duration of hospitalization, or neutropenia. The numbers of days of hyperalimentation, corticosteroids, and antibiotics were similar between both groups. The mean number of antibiotics was greater in the cases versus controls (5.0 versus 2.5; p = .003). There was no difference with respect to total dose or duration of fluconazole administration. Molecular typing of the isolates revealed that four had identical DNA banding patterns, plus another two that differed by one band and were considered related. Three historical strains were unrelated. In conclusion, this report demonstrates that molecular typing can be used to define clonality and, thereby, support increased infection control practices to eliminate such outbreaks when evidence of clonal spread is present.


Morbidity and Mortality Weekly Report | 1997

Outbreak of leptospirosis among white water rafters - Costa Rica 1996.

Boris E. Reisberg; Rebecca Wurtz; P. Diaz; B. Francis; P. Zakowski; S. Fannin; D. Sesline; S. Waterman; R. Sanderson; T. McChesney; R. Boddie; M. Levy; G. Miller; G. Herrera


American Journal of Clinical Pathology | 1999

Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality.

Donna M. Hacek; Terra Suriano; Gary A. Noskin; Julie Kruszynski; Boris E. Reisberg; Lance R. Peterson


Journal of Clinical Microbiology | 1996

Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates.

U R Bodnar; Gary A. Noskin; Terra Suriano; Isabell Cooper; Boris E. Reisberg; Lance R. Peterson


JAMA | 1973

Vancomycin-Streptomycin Synergism in Enterococcal Endocarditis

Grant O. Westenfelder; Philip Y. Paterson; Boris E. Reisberg; Gloria M. Carlson


American Journal of Clinical Pathology | 1998

Cross-contamination of specimens with Mycobacterium tuberculosis: clinical significance, causes, and prevention.

Mondira Bhattacharya; Stephen E. Dietrich; Laura Mosher; Farida Siddiqui; Boris E. Reisberg; William S. Paul; John R. Warren


JAMA | 1997

Outbreak of leptospirosis among white-water rafters - Costa Rica, 1996

Boris E. Reisberg; Rebecca Wurtz


Journal of Antimicrobial Chemotherapy | 1982

Clinical evaluation of moxalactam therapy

Frank R. Venezio; Grant O. Westenfelder; Francis V. Cook; James E. Williams; Mary M. Carruthers; Boris E. Reisberg; Janet Emmerman; John P. Phair

Collaboration


Dive into the Boris E. Reisberg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lance R. Peterson

NorthShore University HealthSystem

View shared research outputs
Top Co-Authors

Avatar

Donna M. Hacek

NorthShore University HealthSystem

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge